Ohio company gets greenlight from FDA to test Cuban drug for diabetic ulcers

  • 📰 clevelanddotcom
  • ⏱ Reading Time:
  • 24 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 63%

@Lll समाचार

Cleveland-Medical-Research,Diabetes,Diabetic-Foot-Ulcers

The drug, which helps close hard-to-heal wounds in diabetic patients, was developed two decades ago and is authorized for use in 26 countries around the world.

CLEVELAND, Ohio— Cleveland-based biotechnology company Discovery Therapeutics Caribe will soon be studying a treatment for diabetic ulcers that was developed in Cuba.

are applied directly to the surface of wounds. However, Heberprot-P is an injection that delivers the active ingredient under the skin, past the chronic wound environment that can otherwise degrade the drug and reduce the effectiveness of the treatment.epidermal growth factor plays a crucial role in the body’s healing process.

Nearly half of patients who undergo lower extremity amputation resulting from diabetic foot ulcers do not survive beyond five years.

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

 /  🏆 301. in İN
 

आपकी टिप्पणी के लिए धन्यवाद। आपकी टिप्पणी समीक्षा के बाद प्रकाशित की जाएगी।

इंडिया ताज़ा खबर, इंडिया मुख्य बातें